Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous monthly C.E.R.A pre-filled syringe study in dialysis patients with chronic kidney disease anemia
2006-004032-75Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta in Uraemic Anaemia, sponsored by Roche. Primary endpoint: Hemoglobin stability within predefined corridor. Started Feb 2007; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2006-004032-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004032-75.